Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
Pablo Palazón‐Riquelme, Jonathan D. Worboys, Jack Green, et al.
EMBO Reports (2018) Vol. 19, Iss. 10
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley, Devon Jeltema, Yanhui Duan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3328-3328
Open Access | Times Cited: 2702
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 533
The NLRP3 inflammasome: activation and regulation
Jie Xu, Gabriel Núñez
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 4, pp. 331-344
Closed Access | Times Cited: 286
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Marlene F. Schmidt, Zhong Yan Gan, David Komander, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 570-590
Open Access | Times Cited: 282
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
Xiaomeng Dai, Lisen Lu, Suke Deng, et al.
Theranostics (2020) Vol. 10, Iss. 20, pp. 9332-9347
Open Access | Times Cited: 190
The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 171
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
Chloe M McKee, Rebecca C. Coll
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 3, pp. 937-952
Open Access | Times Cited: 167
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pablo Pelegrı́n
Biochemical Pharmacology (2020) Vol. 187, pp. 114385-114385
Closed Access | Times Cited: 148
How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 129
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Hu Lei, Hanzhang Xu, Huizhuang Shan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 125
Recent Advances in Small Molecule Inhibitors of Deubiquitinating Enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 4
ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
Guang‐Ming Ren, Xuanyi Zhang, Yang Xiao, et al.
The EMBO Journal (2019) Vol. 38, Iss. 6
Open Access | Times Cited: 130
The NLRP3–inflammasome as a sensor of organelle dysfunction
Paula I. Seoane, Bali Lee, Christopher Hoyle, et al.
The Journal of Cell Biology (2020) Vol. 219, Iss. 12
Open Access | Times Cited: 129
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Anna Gritsenko, Yu Shi, Fatima Martín‐Sánchez, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 122
USP7: Novel Drug Target in Cancer Therapy
Zhiru Wang, Wen-Ting Kang, Yinghua You, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 105
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3
Baoshan Cai, Jian Zhao, Yuling Zhang, et al.
Autophagy (2021) Vol. 18, Iss. 5, pp. 990-1004
Open Access | Times Cited: 94
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
Qiuling Chen, Haoran Yin, Qing‐Yu He, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111442-111442
Open Access | Times Cited: 84
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
Suwen Chen, Yadong Wang, Ya‐mu Pan, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 12
Open Access | Times Cited: 75
Recent insights into the regulatory networks of NLRP3 inflammasome activation
Alexander N.R. Weber, Zsofia Bittner, Sangeetha Shankar, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 23
Open Access | Times Cited: 71
NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
Mahbuba Akther, Md. Ezazul Haque, Jooho Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8780-8780
Open Access | Times Cited: 67
The APPL1-Rab5 axis restricts NLRP3 inflammasome activation through early endosomal-dependent mitophagy in macrophages
Kelvin Ka Lok Wu, Kekao Long, Huige Lin, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
USP7 Inhibition Alleviates H2O2-Induced Injury in Chondrocytes via Inhibiting NOX4/NLRP3 Pathway
Gang Liu, Qingbai Liu, Bin Yan, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 58
Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
Safoura Zangiabadi, Ali A. Abdul‐Sater
The Journal of Immunology (2022) Vol. 208, Iss. 2, pp. 286-292
Open Access | Times Cited: 52
Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3
Xin Liu, Yi Fang, Xinting Lv, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1457-1471
Open Access | Times Cited: 42
E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis
Yuhua Shi, Yang Yang, Weilv Xu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top